These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 31411511

  • 1. Successful Tocilizumab Treatment for Scleritis.
    Poelman HJ, Van Daele PLA, Rothova A.
    Ocul Immunol Inflamm; 2020; 28(2):285-287. PubMed ID: 31411511
    [Abstract] [Full Text] [Related]

  • 2. Sustained Remission with Tocilizumab in Refractory Relapsing Polychondritis with Ocular Involvement: A Case Series.
    Farhat R, Clavel G, Villeneuve D, Abdelmassih Y, Sahyoun M, Gabison E, Sené T, Cochereau I, Titah C.
    Ocul Immunol Inflamm; 2021 Jan 02; 29(1):9-13. PubMed ID: 32643976
    [Abstract] [Full Text] [Related]

  • 3. Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.
    Silpa-Archa S, Oray M, Preble JM, Foster CS.
    Acta Ophthalmol; 2016 Sep 02; 94(6):e400-6. PubMed ID: 27010181
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment with tocilizumab for refractory scleritis associated with relapsing polychondritis.
    Shimizu H, Nishioka H.
    Scand J Rheumatol; 2017 Sep 02; 46(5):418-419. PubMed ID: 28120637
    [No Abstract] [Full Text] [Related]

  • 5. Tocilizumab in Recalcitrant Bilateral Scleritis in a Case of Relapsing Polychondritis: A 17-year Follow Up.
    Doctor M, Murthy SI, Rajasekhar L.
    Ocul Immunol Inflamm; 2023 May 02; 31(4):870-873. PubMed ID: 35695904
    [Abstract] [Full Text] [Related]

  • 6. Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study.
    Samson M, Devilliers H, Ly KH, Maurier F, Bienvenu B, Terrier B, Charles P, Guillevin L, Besancenot JF, Liozon E, Fauchais AL, Loffroy R, Binquet C, Audia S, Seror R, Mariette X, Bonnotte B.
    Eur J Intern Med; 2018 Nov 02; 57():96-104. PubMed ID: 30054122
    [Abstract] [Full Text] [Related]

  • 7. Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial.
    Burmester GR, Buttgereit F, Bernasconi C, Álvaro-Gracia JM, Castro N, Dougados M, Gabay C, van Laar JM, Nebesky JM, Pethoe-Schramm A, Salvarani C, Donath MY, John MR, SEMIRA collaborators.
    Lancet; 2020 Jul 25; 396(10246):267-276. PubMed ID: 32711802
    [Abstract] [Full Text] [Related]

  • 8. [Large-vessel vasculitis-giant cell and Takayasu arteritis].
    Villiger PM.
    Internist (Berl); 2019 Oct 25; 60(10):1059-1073. PubMed ID: 31471629
    [Abstract] [Full Text] [Related]

  • 9. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
    Bijlsma JWJ, Welsing PMJ, Woodworth TG, Middelink LM, Pethö-Schramm A, Bernasconi C, Borm MEA, Wortel CH, Ter Borg EJ, Jahangier ZN, van der Laan WH, Bruyn GAW, Baudoin P, Wijngaarden S, Vos PAJM, Bos R, Starmans MJF, Griep EN, Griep-Wentink JRM, Allaart CF, Heurkens AHM, Teitsma XM, Tekstra J, Marijnissen ACA, Lafeber FPJ, Jacobs JWG.
    Lancet; 2016 Jul 23; 388(10042):343-355. PubMed ID: 27287832
    [Abstract] [Full Text] [Related]

  • 10. Gevokizumab in the Treatment of Autoimmune Non-necrotizing Anterior Scleritis: Results of a Phase I/II Clinical Trial.
    Knickelbein JE, Tucker WR, Bhatt N, Armbrust K, Valent D, Obiyor D, Nussenblatt RB, Sen HN.
    Am J Ophthalmol; 2016 Dec 23; 172():104-110. PubMed ID: 27663070
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of giant cell arteritis: what is in the pipeline?].
    Holle JU, Moosig F.
    Z Rheumatol; 2020 Aug 23; 79(6):516-522. PubMed ID: 32399619
    [Abstract] [Full Text] [Related]

  • 12. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S, Arias-Urdaneta L, Miloslavsky E, Arvikar S, Khosroshahi A, Keroack B, Stone JR, Stone JH.
    Arthritis Care Res (Hoboken); 2012 Nov 23; 64(11):1720-9. PubMed ID: 22674883
    [Abstract] [Full Text] [Related]

  • 13. Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study.
    Bottin C, Fel A, Butel N, Domont F, Remond AL, Savey L, Touitou V, Alexandra JF, LeHoang P, Cacoub P, Bodaghi B, Saadoun D.
    Ocul Immunol Inflamm; 2018 Nov 23; 26(6):915-920. PubMed ID: 28537473
    [Abstract] [Full Text] [Related]

  • 14. Bilateral Posterior Scleritis Associated with Giant Cell Arteritis: A Case Report.
    Erdogan M, Sayin N, Yıldız Ekinci D, Bayramoglu S.
    Ocul Immunol Inflamm; 2018 Nov 23; 26(8):1244-1247. PubMed ID: 28914559
    [Abstract] [Full Text] [Related]

  • 15. Treatment of giant cell arteritis.
    González-Gay MÁ, Pina T, Prieto-Peña D, Calderon-Goercke M, Gualillo O, Castañeda S.
    Biochem Pharmacol; 2019 Jul 23; 165():230-239. PubMed ID: 31034796
    [Abstract] [Full Text] [Related]

  • 16. Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology.
    Teitsma XM, Yang W, Jacobs JWG, Pethö-Schramm A, Borm MEA, Harms AC, Hankemeier T, van Laar JM, Bijlsma JWJ, Lafeber FPJG.
    Arthritis Res Ther; 2018 Oct 15; 20(1):230. PubMed ID: 30322408
    [Abstract] [Full Text] [Related]

  • 17. Development of intracranial vasculitis in giant cell arteritis during tocilizumab treatment.
    Naderi N.
    Clin Exp Rheumatol; 2020 Oct 15; 38 Suppl 124(2):207-209. PubMed ID: 32359040
    [Abstract] [Full Text] [Related]

  • 18. Episcleritis and scleritis: clinical features and treatment results.
    Jabs DA, Mudun A, Dunn JP, Marsh MJ.
    Am J Ophthalmol; 2000 Oct 15; 130(4):469-76. PubMed ID: 11024419
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab.
    Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schulze-Koops H, Schett G, Spiera R, Unizony SH, Collinson N.
    Arthritis Rheumatol; 2019 Aug 15; 71(8):1329-1338. PubMed ID: 30835950
    [Abstract] [Full Text] [Related]

  • 20. Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial.
    Strand V, Dimonaco S, Tuckwell K, Klearman M, Collinson N, Stone JH.
    Arthritis Res Ther; 2019 Feb 20; 21(1):64. PubMed ID: 30786937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.